Amphotericin B Patent Expiration
Amphotericin B was first introduced by Apothecon Inc Div Bristol Myers Squibb
Amphotericin B Patents
Given below is the list of patents protecting Amphotericin B, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Abelcet | US6406713 | Methods of preparing low-toxicity drug-lipid complexes |
Jun 18, 2019
(Expired) | Leadiant Biosci Inc |
| Ambisome | US5965156 | Amphotericin B liposome preparation |
Oct 12, 2016
(Expired) | Astellas |
| Ambisome | US5874104 | Treatment of systemic fungal infections with phospholipid particles encapsulating polyene antibiotics |
Feb 23, 2016
(Expired) | Astellas |
| Abelcet | US5616334 | Low toxicity drug-lipid systems |
Apr 01, 2014
(Expired) | Leadiant Biosci Inc |
Amphotericin B's Family Patents
Explore Our Curated Drug Screens
Amphotericin B Generic API Manufacturers
Several generic applications have been filed for Amphotericin B. The first generic version for Amphotericin B was by Apothecon Inc Div Bristol Myers Squibb and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Eugia Pharma Specialities Ltd and was approved on Nov 17, 2022.
Given below is the list of companies who have filed for Amphotericin B generic, along with the locations of their manufacturing plants worldwide.
1. ABBOTT
Abbott Laboratories has filed for 1 generic for Amphotericin B. Given below are the details of the strengths of this generic introduced by Abbott.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/VIAL | injectable | Discontinued | INJECTION | N/A | Dec 23, 1996 |
Manufacturing Plant Locations New
Abbott's manufacturing plants are situated in 7 countries - United States, Netherlands, United Kingdom, Norway, Germany, France, Ireland. Given below are the details of these plant locations as well as the firm names of Abbott as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||
| Netherlands |
| |||||||||||||
| United Kingdom |
| |||||||||||||
| Norway |
| |||||||||||||
| Germany |
| |||||||||||||
| France |
| |||||||||||||
| Ireland |
| |||||||||||||
2. ABRAXIS PHARM
Abraxis Pharmaceutical Products has filed for 1 generic for Amphotericin B. Given below are the details of the strengths of this generic introduced by Abraxis Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/VIAL | injectable | Discontinued | INJECTION | N/A | Apr 13, 1987 |
3. APOTHECON
Apothecon Inc Div Bristol Myers Squibb has filed for 2 different strengths of generic version for Amphotericin B. All of these versions come by the name FUNGIZONE. Given below are the details of the strengths of this generic introduced by Apothecon.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/VIAL | injectable | Discontinued | INJECTION | N/A | Approved Prior to Jan 1, 1982 |
| 3% | lotion | Discontinued | TOPICAL | N/A | Approved Prior to Jan 1, 1982 |
Manufacturing Plant Locations New
Apothecon's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Apothecon as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
4. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Amphotericin B. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/VIAL | injectable, liposomal | Prescription | INJECTION | AB | Nov 17, 2022 |
Manufacturing Plant Locations New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||
5. SPIL
Sun Pharma Industries Ltd has filed for 1 generic for Amphotericin B. Given below are the details of the strengths of this generic introduced by Spil.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/VIAL | injectable, liposomal | Prescription | INJECTION | AB | Dec 14, 2021 |
Manufacturing Plant Locations New
Spil's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Spil as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
6. TEVA PARENTERAL
Teva Parenteral Medicines Inc has filed for 1 generic for Amphotericin B. Given below are the details of the strengths of this generic introduced by Teva Parenteral.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/VIAL | injectable | Discontinued | INJECTION | N/A | Mar 31, 1995 |
Manufacturing Plant Locations New
Teva Parenteral's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Teva Parenteral as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
7. XGEN PHARMS
Xgen Pharmaceuticals Djb Inc has filed for 1 generic for Amphotericin B. Given below are the details of the strengths of this generic introduced by Xgen Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 50MG/VIAL
(reference standard) | injectable | Prescription | INJECTION | N/A | Apr 29, 1992 |